Lentiviral-mediated Genetic Correction of Hematopoietic and Mesenchymal Progenitor Cells From Fanconi Anemia Patients
Ariana Jacome(Centre for Biomedical Network Research on Rare Diseases), Juan A. Bueren(Centro de Investigación Biomédica en Red), Isabel Badell(Hospital de Sant Pau), Susana Navarro(Centre for Biomedical Network Research on Rare Diseases), Jesús Estella(Hospital Sant Joan de Déu Barcelona), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), José C. Segovia(Unidades Centrales Científico-Técnicas), Julián Sevilla(University of Southern Denmark), Paula Rı́o(Centre for Biomedical Network Research on Rare Diseases), Rosa María Pérez Yáñez(Instituto de Salud Carlos III), José Antonio Casado(Centre for Biomedical Network Research on Rare Diseases), M. Luz Lozano(Centre for Biomedical Network Research on Rare Diseases), Teresa Olivé(Hospital Materno-Infantil), María L. Lamana(Centre for Biomedical Network Research on Rare Diseases), Guillermo Güenechea(Centre for Biomedical Network Research on Rare Diseases), Luís Madero(Hospital Infantil Universitario Niño Jesús), África González‐Murillo(Hospital Infantil Universitario Niño Jesús)
Cited by 49
Related Papers
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
|Haematologica|2014|389
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
|Journal of Allergy and Clinical Immunology|2017|318